STANDARD BIOTOOLS INC. Quarterly Income Tax Expense (Benefit) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Standard Biotools Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2010 to Q3 2024.
  • Standard Biotools Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $118K, a 136% increase year-over-year.
  • Standard Biotools Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $139K, a 79.7% decline year-over-year.
  • Standard Biotools Inc. annual Income Tax Expense (Benefit) for 2023 was $452K.
  • Standard Biotools Inc. annual Income Tax Expense (Benefit) for 2022 was -$2.83M, a 36% increase from 2021.
  • Standard Biotools Inc. annual Income Tax Expense (Benefit) for 2021 was -$4.42M, a 309% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $139K $118K +$68K +136% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $71K $55K -$246K -81.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $317K $128K -$135K -51.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $452K -$162K -$232K -331% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-01
Q3 2023 $684K $50K +$763K Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 -$79K $301K +$1.91M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 -$1.99M $263K +$837K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$2.83M $70K +$883K Oct 1, 2022 Dec 31, 2022 10-K 2024-03-01
Q3 2022 -$3.71M -$713K +$709K +49.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$4.42M -$1.61M -$1.1M -212% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$3.33M -$574K +$1.1M +65.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$4.42M -$813K -$1.8M -182% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-14
Q3 2021 -$2.62M -$1.42M -$1.18M -485% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$1.44M -$517K +$628K +54.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$2.07M -$1.67M -$991K -146% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 -$1.08M $987K +$633K +179% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-08
Q3 2020 -$1.71M -$243K +$925K +79.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$2.64M -$1.15M -$2K -0.18% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 -$2.64M -$680K -$722K -1719% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 -$1.92M $354K +$594K Oct 1, 2019 Dec 31, 2019 10-K 2022-03-08
Q3 2019 -$2.51M -$1.17M -$388K -49.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$2.12M -$1.14M -$939K -460% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 -$1.18M $42K +$1.23M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$2.41M -$240K -$318K -408% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 -$2.09M -$780K -$45K -6.12% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 -$2.04M -$204K +$623K +75.3% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 -$2.67M -$1.18M +$597K +33.5% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 -$3.26M $78K +$2.18M Oct 1, 2017 Dec 31, 2017 10-K 2020-02-27
Q3 2017 -$5.44M -$735K -$426K -138% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 -$5.02M -$827K +$195K +19.1% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 -$5.21M -$1.78M -$1.02M -134% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 -$4.19M -$2.1M -$1.9M -929% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-18
Q3 2016 -$2.3M -$309K +$53K +14.6% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 -$2.35M -$1.02M -$756K -284% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 -$1.59M -$762K -$119K -18.5% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 -$1.48M -$204K +$684K +77% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-08
Q3 2015 -$2.16M -$362K +$354K +49.4% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 -$2.51M -$266K +$862K +76.4% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 -$3.38M -$643K +$1.5M +70% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 -$4.88M -$888K -$930K -2214% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-03
Q3 2014 -$3.95M -$716K -$758K -1805% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 -$3.19M -$1.13M -$1.14M -7620% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 -$2.04M -$2.14M -$2.18M -5739% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 $137K $42K +$7K +20% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-29
Q3 2013 $130K $42K -$19K -31.1% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-06
Q2 2013 $149K $15K +$14K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-04
Q1 2013 $135K $38K -$1K -2.56% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 $136K $35K -$1K -2.78% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-26
Q3 2012 $137K $61K +$41K +205% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-07
Q2 2012 $96K $1K* -$61K Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-07
Q1 2012 $157K $39K -$9K -18.8% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q4 2011 $166K $36K Oct 1, 2011 Dec 31, 2011 10-K 2014-03-12
Q3 2011 $20K +$33K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q2 2011 $62K -$79K -56% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 $48K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q3 2010 -$13K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 $141K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.